-transparent.png){kind=logo}
To determine whether hemoglobin regulation is normal in diseases affecting beta-globin gene expression, globin synthesis was examined in members of a family of a patient with hereditary persistence of fetal hemoglobin/beta o-thalassemia (HPFH/beta o-thal). The HPFH defect is the Ghanian type II, with a deletion from psi beta 1 to at least 20 kb 3' to beta. The beta o-thal gene has the haplotype II restriction enzyme pattern and has the beta 39 nonsense mutation. Erythroid colonies from blood BFU-E were radiolabeled, and globin chains were separated by gel electrophoresis. Colonies from the beta o-thal heterozygote had non-alpha/alpha ratios more balanced than in the reticulocytes. Gamma synthesis was 11% of non-alpha, which is higher than in reticulocytes, but within the range seen in normal adult colonies. Both HPFH heterozygotes produced 20%-30% gamma in erythroid colonies as well as reticulocytes, although non-alpha/alpha was more balanced in the colonies. The HPFH/beta o-thal patient produced 100% gamma in reticulocytes and in colonies. G gamma and gamma-synthetic proportions were not correlated at the individual colony level in the heterozygotes, suggesting that they had "adult" and not "fetal" progenitor cells. The Hb expression of these adult progenitors is presumably modulated normally in vivo in beta o-thal, but the normal decrease in HbF production does not occur in gene deletion HPFH.
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
June 1991,
Hematology/oncology clinics of North America,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
November 1966,
Annals of internal medicine,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
January 1973,
Acta haematologica,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
November 1992,
Clinical chemistry,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
January 1980,
Texas reports on biology and medicine,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
December 1985,
Blood,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
January 1996,
Acta haematologica,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
March 1975,
American journal of human genetics,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
May 1970,
The Journal of clinical investigation,
R S Weinberg, and
S E Antonarakis, and
H H Kazazian, and
G J Dover, and
S H Orkin, and
A L Lenes, and
J M Schofield, and
B P Alter
January 1980,
Hemoglobin,
